Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-7-10
|
pubmed:abstractText |
The alpha-tocopherol transfer protein (alpha-TTP) is a cytosolic liver protein that is presumed to function in the intracellular transport of alpha-tocopherol, the most biologically active form of vitamin E. We studied 4 unrelated patients with autosomal recessive Friedreich-like ataxia who had isolated vitamin E deficiency. A point mutation was identified in all of them at position 101 of the gene for alpha-TTP, where histidine (CAT) was replaced with glutamine (CAG). Three of the 4 patients developed retinitis pigmentosa subsequent to the onset of ataxia. Neurological symptoms included ataxia, dysarthria, hyporeflexia, and decreased proprioceptive and vibratory sensations. Electrophysiological and pathological examinations showed that the cardinal sites affected were the central axons of dorsal root ganglion cells and the retina, with minor involvement of the peripheral sensory nerve, optic nerve, and pyramidal tract. The vitamin E tolerance test performed showed that the absorption of vitamin E was normal but that its decrease from the serum was accelerated. Oral administration of vitamin E appeared to halt the progression of visual and neurological symptoms. We propose a new treatable syndrome of Friedreich-like ataxia and retinitis pigmentosa caused by a defect in the alpha-TTP gene.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0364-5134
|
pubmed:author |
pubmed-author:AraiHH,
pubmed-author:AritaMM,
pubmed-author:GotodaTT,
pubmed-author:HarinoSS,
pubmed-author:ImaiTT,
pubmed-author:InoueKK,
pubmed-author:KandaTT,
pubmed-author:KiyosawaMM,
pubmed-author:MatsumotoHH,
pubmed-author:MizusawaHH,
pubmed-author:OhgaTT,
pubmed-author:ShiojiriTT,
pubmed-author:SuzukiJJ,
pubmed-author:YokotaTT
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
826-32
|
pubmed:dateRevised |
2005-12-6
|
pubmed:meshHeading |
pubmed-meshheading:9189046-Aged,
pubmed-meshheading:9189046-Blotting, Northern,
pubmed-meshheading:9189046-Carrier Proteins,
pubmed-meshheading:9189046-Drug Resistance,
pubmed-meshheading:9189046-Electrophysiology,
pubmed-meshheading:9189046-Female,
pubmed-meshheading:9189046-Friedreich Ataxia,
pubmed-meshheading:9189046-Gene Expression,
pubmed-meshheading:9189046-Humans,
pubmed-meshheading:9189046-Male,
pubmed-meshheading:9189046-Middle Aged,
pubmed-meshheading:9189046-Mutation,
pubmed-meshheading:9189046-Pedigree,
pubmed-meshheading:9189046-Retinitis Pigmentosa,
pubmed-meshheading:9189046-Sural Nerve,
pubmed-meshheading:9189046-Vitamin E
|
pubmed:year |
1997
|
pubmed:articleTitle |
Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene.
|
pubmed:affiliation |
Department of Neurology, Tokyo Medical and Dental University, Japan.
|
pubmed:publicationType |
Journal Article
|